Dow, TeselaGen to Develop Biological Design Automation Platform

TeselaGen Biotechnology and Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Co., will work together to create a state-of-the-art biological design automation platform that should speed discovery work.

“TeselaGen has created a powerful suite of tools for DNA design,” said Daniel R. Kittle, Ph.D., Vice President, Research and Development, Dow AgroSciences. “These tools have the potential to accelerate our discovery efforts focused on providing sustainable solutions to help feed the growing world.”

Advertisement

More about the TeselaGen/Dow collaboration.